Skip to content
IP + Technology Law
Home  »  News & Insights  »  Presentation

Knobbe Practice Webinar Series: Strategic Considerations in Controlling Speed of Prosecution in USPTO

March 18, 2021  | Mauricio Uribe, David Schmidt, Ph.D. and Vlad Teplitskiy

EU Webinar_page_Banner_1_0.png

Partners Mauricio Uribe, David Schmidt and Vlad Teplitskiy presented a webinar focused on strategic considerations in controlling speed of prosecution in USPTO.

View live presentation: Video Link

Knobbe Martens on Vimeo

View and download the full presentation below.
Strategic Considerations in Controlling the Speed of Prosecution at the USPTO 

Strategic Considerations in Controlling the Speed of Prosecution at the USPTO from Knobbe Martens – Intellectual Property Law
Knobbe Practice Webinar Series: Strategic Considerations in Controlling Speed of Prosecution in USPTO Headshot

David Schmidt, Ph.D.
Partner
Orange County
david.schmidt@knobbe.com
949-760-0404
Knobbe Practice Webinar Series: Strategic Considerations in Controlling Speed of Prosecution in USPTO Headshot

Vlad Teplitskiy
Partner
Orange County
vlad.teplitskiy@knobbe.com
949-760-0404

Related Links

Practice Areas

Industries

News & Insights

News
Jun 2026
Sashank Krothapally and Ryan Newell Recognized by USPTO for Pro Bono Patent Prosecution Work
SAN FRANCISCO and NEW YORK, June 15, 2026 – Knobbe Martens is proud to share that associates Sashank Krothapally and Ryan Newell received the U.S. Patent and Trademark Office’s Patent...
News
Jun 2026
Knobbe Martens, Dozens of Partners Receive Top Rankings in IP Law in Legal 500 USA Guide
IRVINE, Calif., June 11, 2026 – Knobbe Martens, a leading intellectual property law firm, is proud to share that the firm and three dozen lawyers received national and regional recognition...
News
May 2026
Knobbe Martens Named Life Sciences Prosecution Firm of the Year at Life Sciences Patent Network Awards
IRVINE, Calif., May 1, 2026 – Knobbe Martens is proud to share the firm received the “Life Sciences Prosecution Firm of the Year” award at the 2026 Life Sciences Patent...